■
9.2.2 利润表
编制单位:金陵药业股份有限公司 2007年1-12月 单位:(人民币)元
■
9.2.3 现金流量表
编制单位:金陵药业股份有限公司 2007年1-12月 单位:(人民币)元
■
■
■
9.2.4 所有者权益变动表(附后)
9.3 与最近一期年度报告相比,会计政策、会计估计和核算方法发生变化的具体说明
√ 适用 □ 不适用
■
9.4 重大会计差错的内容、更正金额、原因及其影响
□ 适用 √ 不适用
9.5 与最近一期年度报告相比,合并范围发生变化的具体说明
□ 适用 √ 不适用
项目 |
本期金额 |
上年金额 |
归属于母公司所有者权益 |
少数股东权益 |
所有者权益合计 |
归属于母公司所有者权益 |
少数股东权益 |
所有者权益合计 |
实收资本(或股本) |
资本公积 |
减:库存股 |
盈余公积 |
一般风险准备 |
未分配利润 |
其他 |
实收资本(或股本) |
资本公积 |
减:库存股 |
盈余公积 |
一般风险准备 |
未分配利润 |
其他 |
一、上年年末余额 |
504,000,000.00 |
467,001,471.30 |
|
195,524,114.32 |
|
392,532,146.15 |
|
147,595,226.22 |
1,706,652,957.99 |
336,000,000.00 |
635,491,251.30 |
|
177,723,890.51 |
|
284,435,369.79 |
|
125,963,135.85 |
1,559,613,647.45 |
加:会计政策变更 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
前期差错更正 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
二、本年年初余额 |
504,000,000.00 |
467,001,471.30 |
|
195,524,114.32 |
|
392,532,146.15 |
|
147,595,226.22 |
1,706,652,957.99 |
336,000,000.00 |
635,491,251.30 |
|
177,723,890.51 |
|
284,435,369.79 |
|
125,963,135.85 |
1,559,613,647.45 |
三、本年增减变动金额(减少以“-”号填列) |
|
9,135,968.00 |
|
26,132,880.80 |
|
170,260,548.46 |
|
37,251,750.50 |
242,781,147.76 |
168,000,000.00 |
-168,489,780.00 |
|
17,800,223.81 |
|
108,096,776.36 |
|
21,632,090.37 |
147,039,310.54 |
(一)净利润 |
|
|
|
|
|
307,465,694.61 |
|
50,205,931.03 |
357,671,625.64 |
|
|
|
|
|
210,135,757.20 |
|
34,132,069.25 |
244,267,826.45 |
(二)直接计入所有者权益的利得和损失 |
|
9,135,968.00 |
|
|
|
-192,265.35 |
|
968,349.20 |
9,912,051.85 |
|
-489,780.00 |
|
|
|
-238,757.03 |
|
-48,478.88 |
-777,015.91 |
1.可供出售金融资产公允价值变动净额 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.权益法下被投资单位其他所有者权益变动的影响 |
|
9,135,968.00 |
|
|
|
|
|
480,012.00 |
9,615,980.00 |
|
670,220.00 |
|
|
|
|
|
|
670,220.00 |
3.与计入所有者权益项目相关的所得税影响 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.其他 |
|
|
|
|
|
-192,265.35 |
|
488,337.20 |
296,071.85 |
|
-1,160,000.00 |
|
|
|
-238,757.03 |
|
-48,478.88 |
-1,447,235.91 |
上述(一)和(二)小计 |
|
9,135,968.00 |
|
|
|
307,273,429.26 |
|
51,174,280.23 |
367,583,677.49 |
|
-489,780.00 |
|
|
|
209,897,000.17 |
|
34,083,590.37 |
243,490,810.54 |
(三)所有者投入和减少资本 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.所有者投入资本 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.股份支付计入所有者权益的金额 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.其他 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(四)利润分配 |
|
|
|
26,132,880.80 |
|
-137,012,880.80 |
|
-13,922,529.73 |
-124,802,529.73 |
|
|
|
17,800,223.81 |
|
-101,800,223.81 |
|
-12,451,500.00 |
-96,451,500.00 |
1.提取盈余公积 |
|
|
|
26,132,880.80 |
|
-26,132,880.80 |
|
|
|
|
|
|
17,800,223.81 |
|
-17,800,223.81 |
|
|
|
2.提取一般风险准备 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.对所有者(或股东)的分配 |
|
|
|
|
|
-110,880,000.00 |
|
-13,922,529.73 |
-124,802,529.73 |
|
|
|
|
|
-84,000,000.00 |
|
-12,451,500.00 |
-96,451,500.00 |
4.其他 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(五)所有者权益内部结转 |
|
|
|
|
|
|
|
|
|
168,000,000.00 |
-168,000,000.00 |
|
|
|
|
|
|
|
1.资本公积转增资本(或股本) |
|
|
|
|
|
|
|
|
|
168,000,000.00 |
-168,000,000.00 |
|
|
|
|
|
|
|
2.盈余公积转增资本(或股本) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.盈余公积弥补亏损 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.其他 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
四、本期期末余额 |
504,000,000.00 |
476,137,439.30 |
|
221,656,995.12 |
|
562,792,694.61 |
|
184,846,976.72 |
1,949,434,105.75 |
504,000,000.00 |
467,001,471.30 |
|
195,524,114.32 |
|
392,532,146.15 |
|
147,595,226.22 |
1,706,652,957.99 |
所有者权益变动表
编制单位:金陵药业股份有限公司 2007年12月31日 单位:(人民币)元
项目 |
本期金额 |
上年金额 |
归属于母公司所有者权益 |
少数股东权益 |
所有者权益合计 |
归属于母公司所有者权益 |
少数股东权益 |
所有者权益合计 |
实收资本(或股本) |
资本公积 |
减:库存股 |
盈余公积 |
一般风险准备 |
未分配利润 |
其他 |
实收资本(或股本) |
资本公积 |
减:库存股 |
盈余公积 |
一般风险准备 |
未分配利润 |
其他 |
一、上年年末余额 |
504,000,000.00 |
467,001,471.30 |
|
195,524,114.32 |
|
392,532,146.15 |
|
147,595,226.22 |
1,706,652,957.99 |
336,000,000.00 |
635,491,251.30 |
|
177,723,890.51 |
|
284,435,369.79 |
|
125,963,135.85 |
1,559,613,647.45 |
加:会计政策变更 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
前期差错更正 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
二、本年年初余额 |
504,000,000.00 |
467,001,471.30 |
|
195,524,114.32 |
|
392,532,146.15 |
|
147,595,226.22 |
1,706,652,957.99 |
336,000,000.00 |
635,491,251.30 |
|
177,723,890.51 |
|
284,435,369.79 |
|
125,963,135.85 |
1,559,613,647.45 |
三、本年增减变动金额(减少以“-”号填列) |
|
9,135,968.00 |
|
26,132,880.80 |
|
170,260,548.46 |
|
37,251,750.50 |
242,781,147.76 |
168,000,000.00 |
-168,489,780.00 |
|
17,800,223.81 |
|
108,096,776.36 |
|
21,632,090.37 |
147,039,310.54 |
(一)净利润 |
|
|
|
|
|
307,465,694.61 |
|
50,205,931.03 |
357,671,625.64 |
|
|
|
|
|
210,135,757.20 |
|
34,132,069.25 |
244,267,826.45 |
(二)直接计入所有者权益的利得和损失 |
|
9,135,968.00 |
|
|
|
-192,265.35 |
|
968,349.20 |
9,912,051.85 |
|
-489,780.00 |
|
|
|
-238,757.03 |
|
-48,478.88 |
-777,015.91 |
1.可供出售金融资产公允价值变动净额 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.权益法下被投资单位其他所有者权益变动的影响 |
|
9,135,968.00 |
|
|
|
|
|
480,012.00 |
9,615,980.00 |
|
670,220.00 |
|
|
|
|
|
|
670,220.00 |
3.与计入所有者权益项目相关的所得税影响 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.其他 |
|
|
|
|
|
-192,265.35 |
|
488,337.20 |
296,071.85 |
|
-1,160,000.00 |
|
|
|
-238,757.03 |
|
-48,478.88 |
-1,447,235.91 |
上述(一)和(二)小计 |
|
9,135,968.00 |
|
|
|
307,273,429.26 |
|
51,174,280.23 |
367,583,677.49 |
|
-489,780.00 |
|
|
|
209,897,000.17 |
|
34,083,590.37 |
243,490,810.54 |
(三)所有者投入和减少资本 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.所有者投入资本 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.股份支付计入所有者权益的金额 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.其他 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(四)利润分配 |
|
|
|
26,132,880.80 |
|
-137,012,880.80 |
|
-13,922,529.73 |
-124,802,529.73 |
|
|
|
17,800,223.81 |
|
-101,800,223.81 |
|
-12,451,500.00 |
-96,451,500.00 |
1.提取盈余公积 |
|
|
|
26,132,880.80 |
|
-26,132,880.80 |
|
|
|
|
|
|
17,800,223.81 |
|
-17,800,223.81 |
|
|
|
2.提取一般风险准备 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.对所有者(或股东)的分配 |
|
|
|
|
|
-110,880,000.00 |
|
-13,922,529.73 |
-124,802,529.73 |
|
|
|
|
|
-84,000,000.00 |
|
-12,451,500.00 |
-96,451,500.00 |
4.其他 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(五)所有者权益内部结转 |
|
|
|
|
|
|
|
|
|
168,000,000.00 |
-168,000,000.00 |
|
|
|
|
|
|
|
1.资本公积转增资本(或股本) |
|
|
|
|
|
|
|
|
|
168,000,000.00 |
-168,000,000.00 |
|
|
|
|
|
|
|
2.盈余公积转增资本(或股本) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.盈余公积弥补亏损 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.其他 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
四、本期期末余额 |
504,000,000.00 |
476,137,439.30 |
|
221,656,995.12 |
|
562,792,694.61 |
|
184,846,976.72 |
1,949,434,105.75 |
504,000,000.00 |
467,001,471.30 |
|
195,524,114.32 |
|
392,532,146.15 |
|
147,595,226.22 |
1,706,652,957.99 |